Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, (editors): Goldfrank's Toxicological Emergencies
Major Players Novo Nordisk Eli Lilly Sanofi AstraZeneca Boehringer Ingelheim Merck & Co
Some experience rapid initial changes, others see gradual but consistent progress
As CNS GSH concentrations are thought to be reduced in PD, a relatively large voxel size was selected in order to maximize signal to noise
Light activity is fine, but avoid intense exercise for the remainder of the day if the injection site feels sore
Possible issues can include: Local irritation Tissue damage Rare allergic reactions [westendmedicalsupply] How Long Does an Unopened Vial Last